Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People.

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Luisa CostanzoClaudio Pedone

Abstract

A universal definition of sarcopenia is still lacking. Since the European criteria have been recently revised, we aimed at studying prevalence of low muscle strength (LMS) and low muscle mass (LMM), as defined according to the European Working Group of Sarcopenia in Older People (EWGSOP) 2 and 1 definitions, and their individual contribution toward mortality and incident mobility disability in a cohort of community-dwelling older people. Longitudinal analysis of 535 participants of the InCHIANTI study. LMS and LMM were defined according to the criteria indicated in the EWGSOP2 and 1. Cox and log-binomial regressions were used to examine association with mortality and 3-year mobility disability (inability to walk 400 m). We observed a lower prevalence of the combination LMM/LMS according to EWGSOP2 compared to EWGSOP1 (3.2% vs 6.2%). Using the new criteria, all sarcopenia components were associated with mortality, although the hazard ratio [HR] for the group LMM/LMS was no longer significant after adjustment for confounders (LMM: HR 2.69, 95% confidence interval [CI] 1.04-6.94; LMS: HR 3.18, 95% CI 1.44-7.01; LMM/LMS: HR 2.95, 95% CI 0.86-10.16). Using EWGSOP1, LMS alone was independently associated with mortality (HR 4.43, 95% ...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Feb 20, 1998·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·M E LachmanE W Peterson
Jun 25, 1999·Research Quarterly for Exercise and Sport·C J JonesW C Beam
Aug 5, 2000·Journal of Applied Physiology·I JanssenR Ross
Feb 11, 2004·American Journal of Epidemiology·Ian JanssenRonenn Roubenoff
Feb 4, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Anne B NewmanTamara B Harris
Nov 2, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Bret H GoodpasterAnne B Newman
Feb 12, 2009·Journal of the American Geriatrics Society·Matteo CesariUNKNOWN Health, Aging and Body Composition Study
Aug 7, 2009·The Journal of Nutrition, Health & Aging·G Abellan van Kan
Oct 30, 2009·The American Journal of Clinical Nutrition·Matthew J DelmonicoUNKNOWN Health, Aging, and Body
Apr 16, 2010·Age and Ageing·Alfonso J Cruz-JentoftUNKNOWN European Working Group on Sarcopenia in Older People
Feb 18, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·S-Y ChuangW-H Pan
Feb 25, 2014·The American Journal of Medicine·Preethi Srikanthan, Arun S Karlamangla
Apr 17, 2014·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Stephanie A StudenskiMaria T Vassileva
Aug 12, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Giuseppe SergiEgle Perissinotto
May 17, 2015·Experimental Gerontology·C BeaudartO Bruyère
May 29, 2015·Geriatrics & Gerontology International·Yeo Hyung KimJae-Young Lim
Aug 15, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Claudio PedoneRaffaele Antonelli Incalzi
Sep 4, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Lara BianchiStefano Volpato
Dec 9, 2015·Australasian Journal on Ageing·Stephen Duckett
Jul 11, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J C MenantS R Lord
Jan 5, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Laura A SchaapMarjolein Visser
Feb 7, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Matteo CesariJohn R Beard
Oct 13, 2018·Age and Ageing·Alfonso J Cruz-JentoftUNKNOWN Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2
Jan 22, 2019·Journal of the American Medical Directors Association·Médéa LocquetOlivier Bruyère
Jan 22, 2019·Journal of the American Medical Directors Association·Steven PhuGustavo Duque

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.